ERBB2 and breast carcinoma: TZB binds specifically and strongly to the extracellular domain IV of the HER2/neu protein found on cancer cells, thus inhibiting the activation of receptor tyrosine- protein kinase erbB-2/proto-oncogene neu (HER2/neu), which leads to inhibition of growth to specific breast cancer cells.